Palvella Therapeutics (PVLA) Tax Rate (2014 - 2025)
Palvella Therapeutics (PVLA) posted quarterly Tax Rate of 1.38% for Q4 2018, down 50.0% year-over-year from 2.77% in Q4 2017, and down 96.72% quarter-over-quarter from 42.17% in Q2 2018.
Powered by 
Analysis
Palvella Therapeutics (PVLA) Tax Rate (2014 - 2025) Analysis & Trends
Palvella Therapeutics (PVLA) has reported Tax Rate for 4 consecutive years, with 1.38% the latest figure, recorded in Q4 2018.
- In Q4 2018, Tax Rate fell 50.0% year-over-year to 1.38%; the TTM figure through Sep 2019 stood at 0.45% (up 40.0% YoY), while the FY2020 annual figure was 0.44%, changed N/A from the prior year.
- Tax Rate fell to 1.38% in Q4 2018 per PVLA's latest filing, from 42.17% in the prior quarter.
- Across five years, Tax Rate topped out at 42.17% in Q2 2018 and bottomed at 8.78% in Q2 2017.
- Historically, Tax Rate has averaged 2.75% across 4 years, with a median of 0.0% in 2014.
- Annual changes were most pronounced in 2015 — Tax Rate slumped 104 bps — and 2018, when it jumped 5095 bps.
- Palvella Therapeutics' Tax Rate stood at 0.0% in 2014, then sank by 1884651 bps to 5.97% in 2015, then jumped by 132 bps to 1.89% in 2017, then declined by 27 bps to 1.38% in 2018.
- Business Quant data shows PVLA's Tax Rate at 1.38% in Q4 2018, 42.17% in Q2 2018, and 1.89% in Q4 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.71% |
| 10 | Palvella Therapeutics | 2.24 Bn | 1.92 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 68.56% |
| Dec 31, 2024 | 92.66% |
| Dec 31, 2018 | 1.38% |
| Jun 30, 2018 | 42.17% |
| Dec 31, 2017 | 1.89% |
| Sep 30, 2017 | -2.11% |
| Jun 30, 2017 | -8.78% |
| Dec 31, 2015 | -5.97% |
| Sep 30, 2015 | -1.04% |
| Sep 30, 2014 | 0.00% |
| Jun 30, 2014 | 0.00% |
| Mar 31, 2014 | 0.00% |